» Articles » PMID: 11340301

Long-term Ammonium Chloride or Sodium Bicarbonate Treatment in Two Models of Polycystic Kidney Disease

Overview
Journal Exp Nephrol
Publisher Karger
Specialty Nephrology
Date 2001 May 8
PMID 11340301
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Administration of ammonium chloride aggravates, while short-term administration of sodium or potassium bicarbonate lessens the development of polycystic kidney disease in Han:SPRD rats. We have conducted studies to determine whether the protection afforded by the administration of sodium bicarbonate is sustained and prevents development of uremia during chronic administration and whether the effects of the administration of ammonium chloride and sodium bicarbonate are also observed in a different model of polycystic kidney disease, the CD1-pcy/pcy mouse. We found that chronic administration of 200 mM sodium bicarbonate to Han:SPRD rats inhibited cystic enlargement and prevented the subsequent development of interstitial inflammation, chronic fibrosis, and uremia. We also found that, while the administration of ammonium chloride has similar effects in Han:SPRD rats and CD1-pcy/pcy mice, the administration of sodium bicarbonate is only protective in the Han:SPRD rats. This probably reflects differences in these models (predominately involvement of proximal tubules in Han:SPRD rats and of collecting ducts and distal tubules in pcy/pcy mice) and the different location and nature of the renal metabolic responses to the administration of acid or alkaline load.

Citing Articles

The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease.

Ferraro P, Bargagli M, Faller N, Anderegg M, Huynh-Do U, Vogt B J Nephrol. 2022; 36(4):1011-1018.

PMID: 36528688 DOI: 10.1007/s40620-022-01540-5.


Low Serum Bicarbonate and CKD Progression in Children.

Brown D, Roem J, Ng D, Reidy K, Kumar J, Abramowitz M Clin J Am Soc Nephrol. 2020; 15(6):755-765.

PMID: 32467307 PMC: 7274283. DOI: 10.2215/CJN.07060619.


Acidosis: progression of chronic kidney disease and quality of life.

de-Brito Ashurst I, OLone E, Kaushik T, McCafferty K, Yaqoob M Pediatr Nephrol. 2014; 30(6):873-9.

PMID: 25085611 DOI: 10.1007/s00467-014-2873-9.


Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells.

Souma T, Abe M, Moriguchi T, Takai J, Yanagisawa-Miyazawa N, Shibata E J Am Soc Nephrol. 2011; 22(4):635-48.

PMID: 21372211 PMC: 3065220. DOI: 10.1681/ASN.2009111130.


Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Kraut J, Madias N Pediatr Nephrol. 2010; 26(1):19-28.

PMID: 20526632 PMC: 2991191. DOI: 10.1007/s00467-010-1564-4.